EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro Antidiabetic Activity and Mechanism of Action of Methanolic Extract of Opuntia stricta Cladodes

Martin Kampamba iD, Christian Chinyere Ezeala iD, Kadango Zombe iD, Angela Gono Bwalya iD

BioMed Research International · 2026-01 · 2026 (1)

DOI: 10.1155/bmri/9325356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioMed Research International, online erschienen am 11.05.2026. Verfasst von Martin Kampamba und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, School of Health Sciences, University of Zambia, Lusaka, Zambia, unza.zm. Hauptthemen laut MEDLINE: Plant Extracts, Hypoglycemic Agents, Opuntia, Diabetes Mellitus, Type 2. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance and β ‐cell dysfunction, leading to chronic hyperglycemia. Although Opuntia species have demonstrated antidiabetic potential, evidence on the in vitro mechanisms of Opuntia stricta cladodes (OSCs) remains limited. This study investigated the antidiabetic activity and mechanism of action of methanolic extracts of OSC using multiple cell‐based assays.

Methods

Cladodes were collected in Zambia, shade‐dried, powdered, and extracted with methanol. Cytotoxicity and antidiabetic effects were assessed using C3A hepatocytes, L6 myoblasts, Caco‐2 epithelial cells, and INS‐1 β ‐cells. Assays included cell viability, glucose utilization, glucose uptake, and β ‐cell proliferation. Data were analyzed using Student′s t ‐test and one‐way ANOVA with Tukey′s post hoc test ( p < 0.05).

Results

The OSC extract showed good tolerability, with cell viability > 80% across all cell lines. In C3A hepatocytes, glucose utilization increased significantly at 6.25–100 μ g/mL ( p < 0.001), with the highest effect at 100 μ g/mL (90.1 % ± 0.3 % ) compared to untreated (86.3 % ± 0.4 % ). Glucose uptake was also significantly enhanced at 100 μ g/mL compared to untreated (51.2 % ± 1.0 % vs. 43.4 % ± 2.5 % , p < 0.001) but without a significant difference from insulin (50.2 % ± 3.6 % , p = 0.984). After 24 h in L6 myoblasts, treatment at 100 μ g/mL modestly but significantly increased glucose utilization compared with untreated controls (95.06 % ± 0.44 % vs. 93.5 % ± 0.59 % , p < 0.005). Uptake also increased significantly at 100 μ g/mL when compared to untreated (53.7 % ± 1.7 % vs. 48.5 % ± 2.6 % , p < 0.005) but was not significantly different from insulin (53.7 % ± 1.7 % vs. 54.3 % ± 2.0 % , p = 0.999). In Caco‐2 cells, glucose uptake decreased compared with untreated controls at 6.25 μ g/mL (57.5 % ± 4.9 % vs. 64.6 % ± 3.6 % , p < 0.05) and 100 μ g/mL (50.8 % ± 9.4 % vs. 64.6 % ± 3.6 % , p < 0.001). In INS‐1 β ‐cells, proliferation increased at 125 μ g/mL after 24 h compared to untreated (111.8 % ± 2.2 % vs. 100.0 % ± 3.8 % , p < 0.001), exceeding 10% fetal bovine serum (FBS) (97.8 % ± 4.1 % ) but declined significantly at 48 and 72 h ( p < 0.05).

Conclusion

OSC extracts enhanced glucose utilization and uptake in C3A hepatocytes and L6 myoblasts to levels similar to insulin, reduced intestinal glucose uptake in Caco‐2 cells relative to untreated controls, and transiently stimulated β ‐cell proliferation beyond that of 10% FBS. These findings highlight OSC as a promising source of antidiabetic bioactives, warranting further molecular and in vivo studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plant ExtractsHypoglycemic AgentsOpuntiaDiabetes Mellitus, Type 2HumansAnimalsGlucoseCell SurvivalCaco-2 CellsMethanolHepatocytesCell ProliferationRatsInsulinCell LineInsulin-Secreting Cells

Substanzen

Plant ExtractsHypoglycemic AgentsGlucoseMethanolInsulin

Autor:innen und Institutionen

  • Department of Pharmacy, School of Health Sciences, University of Zambia, Lusaka, Zambia, unza.zm.
  • College of Health, Agriculture, and Natural Sciences, Africa University, Mutare, Zimbabwe, africau.edu.
  • Department of Chemistry, School of Pure and Applied Sciences, University of Zambia, Lusaka, Zambia, unza.zm.

ORCID-Profile: Martin Kampamba, Christian Chinyere Ezeala, Kadango Zombe, Angela Gono Bwalya

Zitieren

APA

Kampamba, M., Ezeala, C. C., Zombe, K., & Bwalya, A. G. (2026). In Vitro Antidiabetic Activity and Mechanism of Action of Methanolic Extract of Opuntia stricta Cladodes. BioMed Research International, 2026(1). https://doi.org/10.1155/bmri/9325356

Vancouver

Kampamba M, Ezeala CC, Zombe K, Bwalya AG. In Vitro Antidiabetic Activity and Mechanism of Action of Methanolic Extract of Opuntia stricta Cladodes. BioMed Research International. 2026;2026(1). doi:10.1155/bmri/9325356

BibTeX
@article{Kampamba2026,
  author = {Kampamba, Martin and Ezeala, Christian Chinyere and Zombe, Kadango and Bwalya, Angela Gono},
  title = {In Vitro Antidiabetic Activity and Mechanism of Action of Methanolic Extract of Opuntia stricta Cladodes},
  journal = {BioMed Research International},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/bmri/9325356}
}
Kostenlos starten →